NewcelX Ltd.
Pharmaceutical company · Zurich, Switzerland · Nasdaq: NCEL
NewcelX Ltd. is a pharmaceutical company headquartered in Zurich, Switzerland. Its shares trade on Nasdaq under the ticker NCEL. It has reported private securities offerings to the US SEC, most recently $3.4 million sold in a notice filed in 2026.
NewcelX at a glance
What does NewcelX do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $3.4 million sold (2026).
Frequently asked questions about NewcelX
Where is NewcelX headquartered?
NewcelX Ltd. is headquartered in Zurich, Switzerland.
What does NewcelX do?
NewcelX Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is NewcelX a public company?
Yes. NewcelX Ltd. trades on Nasdaq under the ticker NCEL.
Similar companies
- MindMaze Therapeutics Holding SAGeneva, Switzerland
- Novartis AgBasel, Basel-City, Switzerland
- BeOne Medicines Ltd.Basel, Basel-City, Switzerland
- Addex Therapeutics Ltd.Geneva, Switzerland
- MoonLake ImmunotherapeuticsZug, Switzerland
- Oculis Holding AGZug, Switzerland
- ADC Therapeutics SAEpalinges, Vaud, Switzerland
- AC Immune SALausanne, Vaud, Switzerland
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences